JP MORGAN/CALL/TEVA PHARMACEUTICAL INDUSTRIES/16.5/1/20.12.24 Share Price

Warrant

DE000JK9Q4R3

Market Closed - Börse Stuttgart 14:53:00 03/07/2024 BST
1.88 EUR +3.30% Intraday chart for JP MORGAN/CALL/TEVA PHARMACEUTICAL INDUSTRIES/16.5/1/20.12.24
Current month+4.44%
1 month-7.39%
Date Price Change
03/07/24 1.88 +3.30%
02/07/24 1.82 +6.43%
01/07/24 1.71 -5.00%
28/06/24 1.8 -1.10%
27/06/24 1.82 -6.67%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 02:53 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer J.P. Morgan
WKN JK9Q4R
ISINDE000JK9Q4R3
Date issued 22/04/2024
Strike 16.5 $
Maturity 20/12/2024 (170 Days)
Parity 1 : 1
Emission price 0.49
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.5
Lowest since issue 0.53
Delta0.62x
Omega 3.876
Premium14.06x
Gearing6.26x
Moneyness 1.019
Difference Strike -0.32 $
Difference Strike %-1.94%
Spread 1
Spread %33.44%
Theoretical value 2.490
Implied Volatility 51.64 %
Total Loss Probability 51.99 %
Intrinsic value 0.2967
Present value 2.193
Break even 19.19 €
Theta-0.05x
Vega0.04x
Rho0.03x

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.82 USD
Average target price
18.74 USD
Spread / Average Target
+11.39%
Consensus